Paul Walker

3.0k total citations · 1 hit paper
51 papers, 1.7k citations indexed

About

Paul Walker is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Paul Walker has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 8 papers in Epidemiology. Recurrent topics in Paul Walker's work include Chronic Obstructive Pulmonary Disease (COPD) Research (33 papers), Respiratory Support and Mechanisms (17 papers) and Asthma and respiratory diseases (10 papers). Paul Walker is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (33 papers), Respiratory Support and Mechanisms (17 papers) and Asthma and respiratory diseases (10 papers). Paul Walker collaborates with scholars based in United Kingdom, United States and Sweden. Paul Walker's co-authors include Peter M.A. Calverley, P. M. A. Calverley, Sally Singh, Charlotte E. Bolton, Richard W. Costello, William D‐C Man, John Blakey, Sarah Elkin, Louise Sewell and C Michael Roberts and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Paul Walker

50 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE

2013 488 citations Charlotte E. Bolton, Elaine Bevan-Smith et al. Thorax profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Walker United Kingdom	18	1.4k	529	237	186	160	51	1.7k
Md Mostafizur Rahman Bangladesh	4	1.3k 0.9×	544 1.0×	163 0.7×	111 0.6×	110 0.7×	13	1.5k
Ernesto Crisafulli Italy	28	1.8k 1.3×	503 1.0×	335 1.4×	273 1.5×	91 0.6×	125	2.4k
Sylvia Hartl Austria	26	2.1k 1.5×	762 1.4×	224 0.9×	237 1.3×	155 1.0×	89	2.7k
Narelle S. Cox Australia	22	1.5k 1.1×	350 0.7×	192 0.8×	251 1.3×	341 2.1×	86	2.0k
Anders Løkke Denmark	24	1.7k 1.2×	864 1.6×	347 1.5×	121 0.7×	214 1.3×	176	2.4k
Mike Morgan United Kingdom	22	1.5k 1.0×	521 1.0×	126 0.5×	272 1.5×	194 1.2×	60	1.8k
Enric Duran‐Tauleria Spain	24	1.8k 1.3×	1.4k 2.6×	194 0.8×	73 0.4×	231 1.4×	32	2.5k
Takashi Hajiro Japan	22	2.0k 1.4×	952 1.8×	127 0.5×	209 1.1×	283 1.8×	62	2.3k
P. M. A. Calverley United Kingdom	20	2.2k 1.6×	1.4k 2.6×	187 0.8×	120 0.6×	112 0.7×	58	2.8k
Marlies Zwerink Netherlands	11	884 0.6×	174 0.3×	342 1.4×	175 0.9×	419 2.6×	17	1.4k

Countries citing papers authored by Paul Walker

Since Specialization

Citations

This map shows the geographic impact of Paul Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Walker more than expected).

Fields of papers citing papers by Paul Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Walker. The network helps show where Paul Walker may publish in the future.

Co-authorship network of co-authors of Paul Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Walker. A scholar is included among the top collaborators of Paul Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Walker. Paul Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allinson, James P., Simon Brill, Martin Law, et al.. (2023). A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 208(5). 549–558. 5 indexed citations

Ritchie, Andrew I., Simon Brill, Lydia Finney, et al.. (2020). Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 202(4). 549–557. 5 indexed citations

Nightingale, Rebecca, Paul Griffiths, Kevin Mortimer, et al.. (2020). Exploring perspectives on chronic obstructive pulmonary disease in people who smoke heroin: a qualitative study. BJGP Open. 4(3). bjgpopen20X101055–bjgpopen20X101055. 1 indexed citations

Nightingale, Rebecca, Kevin Mortimer, Emanuele Giorgi, et al.. (2019). Screening Heroin Smokers Attending Community Drug Clinics for Change in Lung Function. CHEST Journal. 157(3). 558–565. 10 indexed citations

Wilkinson, Tom, Stuart Schembri, Christopher E. Brightling, et al.. (2019). Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial. Vaccine. 37(41). 6102–6111. 41 indexed citations

Walker, Paul, Pasquale Pio Pompilio, Paolo Zanaboni, et al.. (2018). Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 198(5). 620–628. 104 indexed citations

Burhan, Hassan, et al.. (2018). Screening Heroin Smokers Attending Community Drug Services for COPD. CHEST Journal. 155(2). 279–287. 22 indexed citations

Steiner, Michael, Derek Lowe, John Blakey, et al.. (2017). Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales. Thorax. 72(6). 530–537. 51 indexed citations

Walker, Paul, et al.. (2016). Effect of peripheral arterial disease on the onset of lactate threshold during cardiopulmonary exercise test: study protocol. BMJ Open. 6(12). e012763–e012763. 1 indexed citations

10.

Walker, Paul, et al.. (2015). The Association Between Heroin Inhalation and Early Onset Emphysema. CHEST Journal. 148(5). 1156–1163. 26 indexed citations

11.

West, Malcolm, Matthew G. Parry, Rebecca Asher, et al.. (2015). The Effect of beta-blockade on objectively measured physical fitness in patients with abdominal aortic aneurysms – A blinded interventional study. British Journal of Anaesthesia. 114(6). 878–885. 8 indexed citations

12.

Walker, Paul, et al.. (2015). Commissioning for COPD care: a new, recordable metric that supports the patient interest. Journal of Public Health. 38(2). 396–402. 2 indexed citations

13.

Bolton, Charlotte E., et al.. (2013). Commentary: the British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 68(9). 887–888. 44 indexed citations

14.

Walker, Paul, et al.. (2013). Use of mortality within 30 days of a COPD hospitalisation as a measure of COPD care in UK hospitals. Thorax. 68(10). 968–970. 13 indexed citations

15.

Bolton, Charlotte E., Elaine Bevan-Smith, John Blakey, et al.. (2013). British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE. Thorax. 68(Suppl 2). ii1–ii30. 488 indexed citations breakdown →

16.

Walker, Paul & Peter M.A. Calverley. (2008). The Volumetric Response to Bronchodilators in Stable Chronic Obstructive Pulmonary Disease. COPD Journal of Chronic Obstructive Pulmonary Disease. 5(3). 147–152. 28 indexed citations

17.

Walker, Paul, et al.. (2008). Lung function changes following methacholine inhalation in COPD. Respiratory Medicine. 103(4). 535–541. 16 indexed citations

18.

Stevenson, N., Paul Walker, Richard W. Costello, & Peter M.A. Calverley. (2005). Lung Mechanics and Dyspnea during Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 172(12). 1510–1516. 125 indexed citations

19.

Calverley, P. M. A. & Paul Walker. (2003). Chronic obstructive pulmonary disease. The Lancet. 362(9389). 1053–1061. 162 indexed citations

20.

Walker, Paul. (2000). Vaginal yeasts in the era of "over the counter" antifungals. Sexually Transmitted Infections. 76(6). 437–438. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact